Issue link: https://beckershealthcare.uberflip.com/i/976338
51 GI/ENDOSCOPY The TIF® procedure with the EsophyX® device is an incisionless procedure to control typical and atypical GERD symptoms. In the past 10 years, 4 randomized controlled trials and more than 80 peer-reviewed papers have documented consistent outcomes in over 1,300 unique study patients. So help your patients today with the TIF® procedure. And help Janice regain what was lost. www.EndoGastricSolutions.com The TIF® procedure is designed to treat GERD symptoms with the EsophyX® technology – a cleared device. Results may vary; visit GERDHelp. com for clinical data. EndoGastric Solutions, Inc. is the manufacturer and owner of these trademarks: TIF, EsophyX and SerosaFuse. ©2018 All rights reserved. NP02456-01D GERD has taken a lot from your patients. Help Janice re-claim herself. Janice GERD su erer for 4 years 20 GI companies to know By Eric Oliver and Angie Stewart T he gastrointestinal space offers companies from every spectrum of the industry an opportunity to define their space and develop and sell a superior product. Here are 20 GI companies to know. Allergan Pharmaceuticals (Dublin, Ireland). Allergan is a global pharmaceutical company and leader in the growth pharma industry approach led by Chairman, President and CEO Brent Saunders. With an open science research and develop- ment model, Allergan has partnered with biotech companies, academia and other pharmaceutical companies to establish a broad development pipeline. e company provides products for specialties including the central nervous system, eye care, GI, women's health and urology. Boston Scientific (Marlborough, Mass.). Boston Scientific's endoscopy segment is the most profitable of its rhythm manage- ment branch. With revenues of $1.62 billion in fiscal year 2017, Boston Scientific's endoscopy offerings continue to be a key part of the company's portfolio. e company has a plethora of endoscopic devices designed to treat multiple conditions, tout- ing more than 1,500 technologies to treat GI and pulmonary diseases. Boston Scientific recently acquired EMcision, a London and Montreal, Canada-based endoscopy firm, in early March. Cogentix Medical (Minnetonka, Minn.). Targeting several specialty markets including urology, GI, otolaryngology and pulmonology, Cogentix was formed in 2015 aer Uroplasty and Vision-Sciences merged. e company's flagship GI product is its PrimeSight transnasal esophagoscopy system. e system allows for the immediate and efficient diagnosis of esophageal anatomy. e single-use system decreases disinfection down- time and instrument disinfection. EndoChoice (Alpharetta, Ga.). EndoChoice develops infection control products, pathology services and single-use devices for a wide range of GI conditions. e company was acquired by Marl- borough, Mass.-based Boston Scientific in November 2016. Art Butcher serves as senior vice president and president of endoscopy for Boston Scientific. EndoGastric Solutions (Redmond, Wash.). A medical device company, EndoGastric Solutions focuses on developing and marketing surgical technology for the treatment of gastroesopha- geal reflux disease. Its proprietary platform, the EsophyX fastener delivery system, is used to perform the incisionless transoral fun- doplication procedure. Skip Baldino has served as the company's president and CEO since 2014. Evoke Pharma (Solana Beach, Calif.). Establishing its company Sponsored by: The TIF® procedure with the EsophyX® device is an incisionless procedure to control typical and atypical GERD symptoms. In the past 10 years, 4 randomized controlled trials and more than 80 peer-reviewed papers have documented consistent outcomes in over 1,300 unique study patients. So help your patients today with the TIF® procedure. And help Janice regain what was lost. www.EndoGastricSolutions.com The TIF® procedure is designed to treat GERD symptoms with the EsophyX® technology – a cleared device. Results may vary; visit GERDHelp. com for clinical data. EndoGastric Solutions, Inc. is the manufacturer and owner of these trademarks: TIF, EsophyX and SerosaFuse. ©2018 All rights reserved. NP02456-01D GERD has taken a lot from your patients. Help Janice re-claim herself. Janice GERD su erer for 4 years